Capital and Clinical Rigor Both Land in Wellness

Tulåh Clinical Wellness has opened in Kerala, positioning itself as India's most ambitious medical-wellness center — a clinical, physician-led program built alongside the region's Ayurvedic tradition rather than replacing it. That gives advisors a fresh option to book alongside, or instead of, Ananda in the Himalayas for clients seeking medically supervised longevity programs rather than pure spa-and-yoga retreats.

For specialist advisors, early positioning matters: properties this new typically move quickly from insider-only to fully booked once word spreads, and being able to speak knowledgeably about program structure, screening requirements, and how it differs from established Kerala Ayurveda resorts is a real differentiator. Worth flagging to longevity-focused clients now, before it appears on every competitor's radar. Confirm current medical-screening and program-length requirements directly with the property, as these details are still emerging.

Bain Capital has acquired UK supplements maker Vitabiotics for $1.2 billion, one of the largest private-equity bets yet on the wellness-adjacent consumer sector. The deal is a macro signal rather than a booking one: it shows institutional capital treating nutraceuticals and longevity-adjacent brands as a serious asset class, which tends to accelerate consolidation among the supplement and diagnostics partners that longevity clinics and destination spas co-brand with.

Advisors won't see immediate itinerary impact, but it's worth tracking which supplement and diagnostics brands your go-to clinics and spas partner with — PE ownership can bring pricing changes, reformulated product lines, or shifts in which properties get preferred access to a given brand's programs. Consider it an early indicator of where the wellness economy's capital, and eventually its programming, is heading.